Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Consulting agrmnt
Appointed COO
|
|
Pharma-Bio Serv, Inc. (PBSV)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/17/2023 |
8-K
| Quarterly results|
Docs:
|
"DORADO, PUERTO RICO / ACCESSWIRE / March 17, 2023 / Pharma-Bio Serv, Inc. , a compliance, project management and technology transfer support consulting firm that provides services to the pharmaceutical, biotechnology, chemical, medical device, cosmetic, food and allied products industries, today announced that revenues for the quarter ended January 31, 2023 were approximately $4.2 million, a net decrease of approximately $0.8 million when compared to the same period last year. Net income for the quarter ended January 31, 2023 was approximately $0.4 million, an increase of approximately $0.1 million when compared to the same period last year. "This quarter we were able to successfully maximize our resources in more profitable markets. This strategy yielded a positive effect on our overall g..." |
|
| 01/30/2023 |
8-K
| Quarterly results|
Docs:
|
"DORADO, PUERTO RICO / ACCESSWIRE / January 30, 2023 / Pharma-Bio Serv, Inc. , is a regulatory, compliance, project management and technology transfer support consulting firm that provides services to the pharmaceutical, biotechnology, medical device, cosmetic, food and allied products industries. Today, Pharma-Bio Serv announced that revenues for the year ended October 31, 2022 were approximately $19.4 million, a decrease of approximately $0.7 million when compared to last year. Additionally, net income for the year ended October 31, 2022 was approximately $1.0 million, an improvement of approximately $3.0 million when compared to last year. The net income variance is mostly due to the recording of an account receivable provision of approximately $5.2 million in 2021 which was partially of..." |
|
| 09/14/2022 |
8-K
| Quarterly results|
Docs:
|
"DORADO, PUERTO RICO / ACCESSWIRE / September 14, 2022 / Pharma-Bio Serv, Inc. , a compliance, project management and technology transfer support consulting firm providing services to the pharmaceutical, biotechnology, chemical, medical device, cosmetic, food and allied products industries, today announced that revenues for the three and nine months ended July 31, 2022 were approximately $4.8 and $14.8 million, respectively. This represents a decrease of approximately $0.2 million and an increase of $0.2 million, for three and nine months respectively, when compared to the same periods last year. Net income for the three and nine months ended July 31, 2022 was approximately $0.3 and $0.8 million, respectively, a decrease for both periods of approximately $2.0 million when compared to the sa..." |
|
| 03/17/2022 |
8-K
| Quarterly results|
Docs:
|
"DORADO, PUERTO RICO / ACCESSWIRE / March 17, 2022 / Pharma-Bio Serv, Inc. , a compliance, project management and technology transfer support consulting firm that provides services to the pharmaceutical, biotechnology, chemical, medical device, cosmetic, food and allied products industries, today announced that revenues for the quarter ended January 31, 2022 were approximately $5.0 million, an increase of approximately $0.5 million when compared to the same period last year. Net income for the quarter ended January 31, 2022 was approximately $0.3 million, reflecting no significant change when compared to the same period last year. “Our efforts to diversify and expand our geographical revenue should be noted in this quarter’s results. The continental US and Europe consulting markets represen..." |
|
| 02/14/2022 |
8-K
| Quarterly results |
| 09/14/2021 |
8-K
| Quarterly results |
| 06/14/2021 |
8-K
| Quarterly results |
| 03/17/2021 |
8-K
| Quarterly results |
| 02/01/2021 |
8-K
| Quarterly results |
| 06/15/2020 |
8-K
| Quarterly results|
Docs:
|
"DORADO, PUERTO RICO / ACCESSWIRE / June 15, 2020 / Pharma-Bio Serv, Inc. , a compliance, project management and technology transfer support consulting firm that provides services to the pharmaceutical, biotechnology, chemical, medical device, cosmetic, food and allied products industries, today announced revenues for the three and six months ended April 30, 2020 were $5,648,000 and $10,261,000, respectively, an increase of approximately $498,000 and $545,000, or 9.7% and 5.6%, respectively, when compared to the same periods last year." |
|
| 03/16/2020 |
8-K
| Quarterly results |
| 01/29/2020 |
8-K
| Quarterly results |
| 09/16/2019 |
8-K
| Quarterly results|
Docs:
|
"DORADO, PUERTO RICO / ACCESSWIRE / September 16, 2019 / Pharma-Bio Serv, Inc. , a compliance, project management and technology transfer support consulting firm that provides services to the pharmaceutical, biotechnology, chemical, medical device, cosmetic, food and allied products industries, today announced revenues from continuing operations for the three and nine months ended July 31, 2019 were $5.0 and $14.7 million, respectively, an increase of approximately $0.3 and $2.6 million, or 7% and 21%, respectively, when compared to the same periods last year." |
|
| 06/14/2019 |
8-K
| Quarterly results |
| 03/18/2019 |
8-K
| Quarterly results |
| 01/29/2019 |
8-K
| Quarterly results |
| 09/14/2018 |
8-K
| Quarterly results|
Docs:
|
"DORADO, PUERTO RICO / ACCESSWIRE / September 14, 2018 / Pharma-Bio Serv, Inc. , a compliance and project management consulting firm, that provides services to the pharmaceutical, biotechnology, chemical, medical device, cosmetic, food and allied products industries, today announced net revenues for the three and nine months ended July 31, 2018 were $5.2 and $13.8 million, respectively, an increase of approximately $1.2 and $1.9 million, or 31.0% and 15.8%, respectively, when compared to the same periods last year." |
|
| 06/14/2018 |
8-K
| Quarterly results|
Docs:
|
"DORADO, PUERTO RICO / ACCESSWIRE / June 14, 2018 / Pharma-Bio Serv, Inc. , a compliance and project management consulting firm, that provides services to the pharmaceutical, biotechnology, chemical, medical device, cosmetic, food and allied products industries, today announced net revenues for the three and six months ended April 30, 2018 were $4.4 and $8.6 million, respectively, an increase of approximately $0.5 and $0.7 million, or 12.3% and 8.2%, respectively, when compared to the same periods last year." |
|
| 03/19/2018 |
8-K
| Quarterly results|
Docs:
|
"DORADO, PUERTO RICO / ACCESSWIRE / March 19, 2018 / Pharma-Bio Serv, Inc. , a compliance, project management and technology transfer support consulting firm, that provides services to the pharmaceutical, biotechnology, chemical, medical device, cosmetic, food and allied products industries, today announced net revenues for the quarter ended January 31, 2018 were $4.2 million, an increase of $0.2 million when compared to the same period last year." |
|
| 09/14/2017 |
8-K
| Quarterly results |
| 06/14/2017 |
8-K
| Form 8-K - Current report |
| 03/17/2017 |
8-K
| Form 8-K - Current report |
| 01/30/2017 |
8-K
| Form 8-K - Current report |
| 09/14/2016 |
8-K
| Quarterly results|
Docs:
|
"Pharma-Bio Serv Announces Results for the Quarter Ended July 31, 2016 DORADO, PUERTO RICO / ACCESSWIRE / September 14, 2016 / Pharma-Bio Serv, Inc. , a compliance, project management and technology transfer support consulting firm, that provides services to the pharmaceutical, biotechnology, chemical, medical device, cosmetic, food and allied products industries, today announced net revenues for the three and nine months ended July 31, 2016 were $4.9 million and $14.9 million, respectively, a decrease of approximately $1.3 million and $2.6 million, or 21.3% and 14.9%, respectively, when compared to the same periods last year." |
|
| 06/14/2016 |
8-K
| Quarterly results|
Docs:
|
"Pharma-Bio Serv Announces Results for the Quarter Ended April 30, 2016 DORADO, PUERTO RICO / ACCESSWIRE / June 14, 2016 / Pharma-Bio Serv, Inc. , a compliance, project management and technology transfer support consulting firm, that provides services to the pharmaceutical, biotechnology, chemical, medical device, cosmetic, food and allied products industries, today announced revenues for the three and six months ended April 30, 2016 were $5.1 and $10.0 million, respectively, a decrease of approximately $0.3 and $1.3 million, or 5.7% and 11.4%, respectively, when compared to the same periods last year. The decline for the three months ended April 30, 2016, when compared to the same period last year, is mainly attributable to a decline in projects in the Puerto Rico, United States and Europe..." |
|
| 03/16/2016 |
8-K
| Form 8-K - Current report |
| 01/29/2016 |
8-K
| Quarterly results |
| 09/14/2015 |
8-K
| Quarterly results|
Docs:
|
"Forward Looking Statements This news release contains "forward-looking statements" within the meaning of the U.S. federal securities laws, which statements may include information regarding the plans, intentions, expectations, future financial performance, or future operating performance of Pharma-Bio Serv. Forward-looking statements are based on the expectations, estimates, or projections of management as of the date of this news release. Although Pharma-Bio Serv's management believes these expectations, estimates, or projections to be reasonable as of the date of this news release, forward-looking statements are inherently subject to significant business risks, economic and competitive uncertainties, or other contingencies, which could cause its actual results or performance to differ ma..." |
|
| 03/17/2015 |
8-K
| Quarterly results|
Docs:
|
"Pharma-Bio Serv Announces Results for the Quarter Ended January 31, 2015 DORADO, PUERTO RICO / ACCESSWIRE / March 17, 2015 / Pharma-Bio Serv, Inc. , a compliance, project management and technology transfer support consulting firm, that provides services to the pharmaceutical, biotechnology, chemical, medical device, cosmetic, food and allied products industries, today announced net revenues for the three months ended January 31, 2015 were $5.9 million, a decrease of approximately $1.1 million, or 16%, when compared to the same period last year. This decline is mainly attributable to a $1.5 and $0.3 million revenue decrease in the United States and Europe consulting markets, respectively, offset by a gain in the Puerto Rico consulting business of approximately $0.7 million, of which $0.4 mi..." |
|
| 01/29/2015 |
8-K
| Quarterly results |
| 09/25/2007 |
8-K/A
| Quarterly results |
| 09/19/2007 |
8-K
| Quarterly results |
| 06/25/2007 |
8-K
| Quarterly results |
| 03/21/2007 |
8-K
| Quarterly results |
|
|